NovoCure's market cap is currently $1.51B. The company's EPS TTM is $-0.33; its P/E ratio is -8.36; NovoCure is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
